138 related articles for article (PubMed ID: 21494118)
1. Hepatocyte nuclear factor (HNF) 4α expression distinguishes ampullary cancer subtypes and prognosis after resection.
Ehehalt F; Rümmele P; Kersting S; Lang-Schwarz C; Rückert F; Hartmann A; Dietmaier W; Terracciano L; Aust DE; Jahnke B; Saeger HD; Pilarsky C; Grützmann R
Ann Surg; 2011 Aug; 254(2):302-10. PubMed ID: 21494118
[TBL] [Abstract][Full Text] [Related]
2. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
4. Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections.
Duffy JP; Hines OJ; Liu JH; Ko CY; Cortina G; Isacoff WH; Nguyen H; Leonardi M; Tompkins RK; Reber HA
Arch Surg; 2003 Sep; 138(9):941-8; discussion 948-50. PubMed ID: 12963649
[TBL] [Abstract][Full Text] [Related]
5. Pathological factors influencing survival of carcinoma of the ampulla of Vater.
Mori K; Ikei S; Yamane T; Yamaguchi Y; Katsumori T; Shibata Y; Arai T
Eur J Surg Oncol; 1990 Jun; 16(3):183-8. PubMed ID: 2347413
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of histological blood vessel invasion in patients with ampullary adenocarcinoma.
Kawaguchi T; Ochiai T; Ikoma H; Inoue K; Morimura R; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Nakanishi M; Ichikawa D; Okamoto K; Fujiwara H; Kokuba Y; Sonoyama T; Otsuji E
Hepatogastroenterology; 2010; 57(104):1347-50. PubMed ID: 21443083
[TBL] [Abstract][Full Text] [Related]
8. A survival predictive model in patients undergoing radical resection of ampullary adenocarcinoma.
Wang CH; Mo LR; Lin RC; Kuo JJ; Chang KK; Lin YW; Yang DM; Yau MP; Cho CY
Hepatogastroenterology; 2004; 51(59):1495-9. PubMed ID: 15362785
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
Roder JD; Siewert JR
Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
[TBL] [Abstract][Full Text] [Related]
10. Survival after resection of ampullary carcinoma: a national population-based study.
O'Connell JB; Maggard MA; Manunga J; Tomlinson JS; Reber HA; Ko CY; Hines OJ
Ann Surg Oncol; 2008 Jul; 15(7):1820-7. PubMed ID: 18369675
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients.
Santini D; Vincenzi B; Tonini G; Scarpa S; Vasaturo F; Malacrino C; Vecchio F; Borzomati D; Valeri S; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
Clin Cancer Res; 2005 May; 11(10):3784-9. PubMed ID: 15897577
[TBL] [Abstract][Full Text] [Related]
12. Survival and prognostic factors in pancreatic and ampullary cancer.
Lemke J; Schäfer D; Sander S; Henne-Bruns D; Kornmann M
Anticancer Res; 2014 Jun; 34(6):3011-20. PubMed ID: 24922667
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.
Santini D; Tonini G; Vecchio FM; Borzomati D; Vincenzi B; Valeri S; Antinori A; Castri F; Coppola R; Magistrelli P; Nuzzo G; Picciocchi A
J Clin Pathol; 2005 Feb; 58(2):159-65. PubMed ID: 15677536
[TBL] [Abstract][Full Text] [Related]
14. [Results of cephalic pancreaticoduodenectomy for ampullary carcinoma. Analysis of 18 consecutive cases].
Casaretto E; Andrada DG; Granero LE
Acta Gastroenterol Latinoam; 2010 Mar; 40(1):22-31. PubMed ID: 20446393
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of extracapsular lymph node involvement in patients with adenocarcinoma of the ampulla of Vater.
van der Gaag NA; ten Kate FJ; Lagarde SM; Busch OR; van Gulik TM; Gouma DJ
Br J Surg; 2008 Jun; 95(6):735-43. PubMed ID: 18300268
[TBL] [Abstract][Full Text] [Related]
17. [The long term results and survival prognostic factors of surgical treatment ampulla Vateri cancer].
Alibegov RA; Prokhorenko TI; Sergeev OA; Khlusov AN
Khirurgiia (Mosk); 2008; (4):27-30. PubMed ID: 18454104
[TBL] [Abstract][Full Text] [Related]
18. Is local resection adequate for T1 stage ampullary cancer?
Amini A; Miura JT; Jayakrishnan TT; Johnston FM; Tsai S; Christians KK; Gamblin TC; Turaga KK
HPB (Oxford); 2015 Jan; 17(1):66-71. PubMed ID: 25395092
[TBL] [Abstract][Full Text] [Related]
19. Tumor-related factors and patient's age influence survival after resection for ampullary adenocarcinoma.
Barauskas G; Gulbinas A; Pranys D; Dambrauskas Z; Pundzius J
J Hepatobiliary Pancreat Surg; 2008; 15(4):423-8. PubMed ID: 18670845
[TBL] [Abstract][Full Text] [Related]
20. Number of positive lymph nodes independently affects long-term survival after resection in patients with ampullary carcinoma.
Sakata J; Shirai Y; Wakai T; Yokoyama N; Sakata E; Akazawa K; Hatakeyama K
Eur J Surg Oncol; 2007 Apr; 33(3):346-51. PubMed ID: 17097846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]